Australia markets closed

iBio, Inc. (IBIO)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.6200-0.2200 (-7.75%)
At close: 04:00PM EDT
2.6200 0.00 (0.00%)
After hours: 07:22PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/06/2024
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
-24,907
-24,907
-65,010
-50,391
-23,207
-
Depreciation & amortisation
1,250
1,250
1,380
3,791
2,414
-
Stock-based compensation
2,038
2,038
4,391
4,377
1,586
-
Change in working capital
-3,168
-3,168
5,869
3,243
-11,154
-
Accounts receivable
0
0
1,000
-886
-426
-
Inventory
0
0
-1,015
-3,873
772
-
Accounts payable
-1,491
-1,491
-625
1,239
48
-
Other working capital
-18,764
-18,764
-36,174
-49,110
-35,226
-
Other non-cash items
32
32
167
-52
-56
-
Net cash provided by operating activities
-18,554
-18,554
-30,436
-37,480
-30,064
-
Cash flows from investing activities
Investments in property, plant and equipment
-210
-210
-5,738
-11,630
-5,162
-
Acquisitions, net
0
0
-692
0
-
-
Purchases of investments
-
-
0
-7,115
-23,816
0
Sales/maturities of investments
0
0
10,839
13,618
4,000
-
Other investing activities
-
-
-
-
-1,500
-
Net cash used for investing activities
906
906
7,009
-5,127
-26,478
-
Cash flows from financing activities
Debt repayment
-2,033
-2,033
-9,625
-5,830
-331
-
Common stock issued
25,523
25,523
11,487
0
-
-
Common stock repurchased
-7
-7
-39
0
-
-
Other financing activities
116
116
-22
-372
836
-
Net cash used provided by (used for) financing activities
24,494
24,494
2,301
-6,125
78,835
-
Net change in cash
6,846
6,846
-21,093
-48,732
22,292
-
Cash at beginning of period
7,579
7,579
28,672
77,404
55,112
-
Cash at end of period
14,425
14,425
7,579
28,672
77,404
-
Free cash flow
Operating cash flow
-18,554
-18,554
-30,436
-37,480
-30,064
-
Capital expenditure
-210
-210
-5,738
-11,630
-5,162
-
Free cash flow
-18,764
-18,764
-36,174
-49,110
-35,226
-